The UK’s FTSE 100 experienced a decline on Monday, driven by a decrease in AstraZeneca shares following reports of a possible collaboration with U.S. drugmaker Bristol Myers Squibb. Additionally, lower oil prices negatively impacted energy giants BP and Shell. The blue-chip FTSE 100 index fell 0.10% to 10,857.49 points by 0931, while the mid-cap FTSE Read More
On Tuesday, London’s FTSE 100 experienced an uptick, driven primarily by advancements in the financial and industrial sectors, as a decline in oil prices bolstered investor risk appetite. Oil prices have declined to a three-month low, continuing the downward trend from the prior session following a preliminary peace agreement between the U.S. and Iran aimed Read More
